4 unknown. 4 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 3 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases COVID-19 vaccine - Rheumatoid Arthritis, Autoimmune Rheumatologic Disease | Phase 2 / Phase 3 | Unknown | Paul R Fortin | 287 | 2022-03-09 | 2023-01-17 |
| Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study Cutaneous iontophoresis of treprostinil - Scleroderma, Systemic | Phase 1 / Phase 2 | Unknown | University Hospital, Grenoble | 40 | 2012-02-01 | 2013-07-18 |
| AIMSPRO in Established Diffuse Cutaneous Systemic Sclerosis Hyperimmune caprine serum, Albumin - Systemic Sclerosis | Phase 2 | Unknown | Daval International Limited | 20 | 2008-12-01 | 2011-08-18 |
| High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis N-acetylcysteine (NAC) - Scleroderma, Diffuse | Phase 2 / Phase 3 | Unknown | Università Politecnica delle Marche | 45 | 2007-01-01 | 2007-01-30 |
Scleroderma, Systemic (4) · Arthritis, Rheumatoid (1) · Lupus Erythematosus, Systemic (1) · MASS syndrome (1) · Systemic Vasculitis (1) · Undifferentiated Connective Tissue Diseases (1)
Connective Tissue Diseases (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Arthritis (1) · Autoimmune Diseases (1) · Cardiovascular Diseases (1) · Immune System Diseases (1) · Joint Diseases (1) · Musculoskeletal Diseases (1) · Rheumatic Diseases (1) · Vascular Diseases (1) · Vasculitis (1)
Acetylcysteine (1) · Albumins (1) · COVID-19 Vaccines (1)
Daval International Limited (1) · Paul R Fortin (1) · University Hospital, Grenoble (1) · Università Politecnica delle Marche (1)
Canada (1) · France (1) · Italy (1) · United Kingdom (1)
Armando Gabrielli, MD,professor (1) · Christopher P Denton, PhD FRCP (1) · Jean-Luc Cracowski, MD (1) · Paul R Fortin, MD,MPH,FRCPC (1)